Neuropeptide Regulation of Immunity: The Immunosuppressive Activity of Alpha‐Melanocyte‐Stimulating Hormone (α‐MSH)

Abstract

Abstract: The ocular microenvironment is an extreme example of regional immunity. Within its microenvironment, expression of delayed type hypersensitivity (DTH) is suppressed. This immunosuppression is mediated in part by the constitutive expression of α‐MSH. Previously we have found that α‐MSH suppresses the production of IFN‐γ by activated effector T cells. Recently we have found that α‐MSH can mediate induction of TGF‐β‐producing T cells that act as regulatory T cells. This has encouraged us to further examine the potential for α‐MSH to suppress T cell‐mediated inflammation (autoimmune disease) and to regulate lymphokine production by effector T cells. When α‐MSH was injected i.v. into mice at the time of peak retinal inflammation, the severity of experimental autoimmune uveitis (EAU) was significantly suppressed. Effector T cells activated in vitro in the presence of α‐MSH proliferated and produced IL‐4 and enhanced levels of TGF‐β while their IFN‐γ and IL‐10 production was suppressed. The α‐MSH‐treated T cells functioned as regulatory T cells by suppressing in vitro IFN‐γ production by other inflammatory T cells. This regulatory activity was the function of α‐MSH‐treated CD4+ CD25+ T cells. Therefore, α‐MSH mediates immunosuppression by inducing a differential expression of lymphokine production and by inducing activation of regulatory functions in T cells. This implies that α‐MSH may take part in regional mechanisms of immunosuppression and possibly peripheral tolerance. Thus, α‐MSH can be used to suppress autoimmune disease and possibly reestablish tolerance to autoantigens.

Key Biomarkers

Symptom Clusters